<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2210-1-4.anc" start="67" end="73" sStart="43" offset="24" sid="r7.serve.v.0864" wn="1" wnkey="serve%2:42:03::" text="The lower urinary tract serves to store and periodically eliminate urine." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-4.anc" start="30596" end="30601" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="2 ml into the bladder the distal, cut end of the pelvic nerve was stimulated with a long train (5 Hz; 1 msec pulse width; 60 sec train; 30-300 (uamps) to elicit a prolonged contraction displaying two phases: Phase I, a &lt;b&gt;rapid&lt;/b&gt; contraction and Phase II, a plateau phase [ 20 21 ] . Phase I is resistant to atropine, and therefore is mostly due to non-adrenergic, non-cholinergic activation, whereas Phase II is highly sensitive to muscarinic blockade [ 21 ] . Olanzapine (n = 4) and risperidone (n = 4) were administered (0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-4.anc" start="30596" end="30601" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="2 ml into the bladder the distal, cut end of the pelvic nerve was stimulated with a long train (5 Hz; 1 msec pulse width; 60 sec train; 30-300 (uamps) to elicit a prolonged contraction displaying two phases: Phase I, a &lt;b&gt;rapid&lt;/b&gt; contraction and Phase II, a plateau phase [ 20 21 ] . Phase I is resistant to atropine, and therefore is mostly due to non-adrenergic, non-cholinergic activation, whereas Phase II is highly sensitive to muscarinic blockade [ 21 ] . Olanzapine (n = 4) and risperidone (n = 4) were administered (0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-4.anc" start="30596" end="30601" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="2 ml into the bladder the distal, cut end of the pelvic nerve was stimulated with a long train (5 Hz; 1 msec pulse width; 60 sec train; 30-300 (uamps) to elicit a prolonged contraction displaying two phases: Phase I, a &lt;b&gt;rapid&lt;/b&gt; contraction and Phase II, a plateau phase [ 20 21 ] . Phase I is resistant to atropine, and therefore is mostly due to non-adrenergic, non-cholinergic activation, whereas Phase II is highly sensitive to muscarinic blockade [ 21 ] . Olanzapine (n = 4) and risperidone (n = 4) were administered (0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-4.anc" start="30596" end="30601" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="2 ml into the bladder the distal, cut end of the pelvic nerve was stimulated with a long train (5 Hz; 1 msec pulse width; 60 sec train; 30-300 (uamps) to elicit a prolonged contraction displaying two phases: Phase I, a &lt;b&gt;rapid&lt;/b&gt; contraction and Phase II, a plateau phase [ 20 21 ] . Phase I is resistant to atropine, and therefore is mostly due to non-adrenergic, non-cholinergic activation, whereas Phase II is highly sensitive to muscarinic blockade [ 21 ] . Olanzapine (n = 4) and risperidone (n = 4) were administered (0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2210-1-4.anc" start="30596" end="30601" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="2 ml into the bladder the distal, cut end of the pelvic nerve was stimulated with a long train (5 Hz; 1 msec pulse width; 60 sec train; 30-300 (uamps) to elicit a prolonged contraction displaying two phases: Phase I, a &lt;b&gt;rapid&lt;/b&gt; contraction and Phase II, a plateau phase [ 20 21 ] . Phase I is resistant to atropine, and therefore is mostly due to non-adrenergic, non-cholinergic activation, whereas Phase II is highly sensitive to muscarinic blockade [ 21 ] . Olanzapine (n = 4) and risperidone (n = 4) were administered (0." />
  </sentences>
</list>